Therapy Market Research Reports & Industry Analysis

... infections during the treatment were not available. If that fails, the gains ... super infections” warranting need for new classes of antibiotics and other preventive/therapeutic approaches ... Gram Negative infections and CRE. Pipeline of novel targets being used to develop new drugs to treat infections and resistance ...

... bigger for newer options than late stage if they succeed.In coming years, we expect second generation antiandrogens (Androgen synthesis inhibitors/Androgen receptor inhibitors, Xtandi, ARN-509, ODM-021, Zytiga, TAK-700, TOK-001) to replace ...

... in the pre-clinical studies. There are many applications of the peptide drugs. The most popular and dominant segments include cancer ... demand for peptide drugs, this market is expected to grow at a CAGR of 9-10% to reach approximately USD 27.3 billion by 2018. “Global Peptide Therapeutics Market & Pipeline ...

... lymphocytic/lymphoblastic leukemia may also occur in adults. The acute lymphocytic/lymphoblastic leukemia market is segmented into two types—childhood acute lymphocytic/lymphoblastic leukemia and adult acute lymphocytic/lymphoblastic leukemia. The acute lymphocytic/lymphoblastic leukemia therapeutics market ...

... is increasing at an alarming rate. According to RNCOS’ report “Booming IVF Market in India”, the IVF market is poised to witness impressive CAGR of around 14% over ... region-wise i.e. their penetration across East/West/North/South India; their structure i.e. chain, independent and hospital-based; the number of ...

... IUI, IVF, and ICSI (intra cytoplasmic sperm injection). India has become one of the favored destinations for infertility treatments such as IVF due to several ... health care system. “India IVF Treatment Market Outlook 2018” report by KuicK Research gives comprehensive insight on following aspects related to booming IVF treatment market in India: Market Overview IVF Treatment Market Potential Total Fertility ...

... Scope of the report The report titled “Global Rheumatoid Arthritis Market: Trends and Opportunities (2013-2018)” provides an in-depth analysis of global rheumatoid arthritis market with special focus on biologics drugs. It also accesses the key opportunities and underlying trends in the market and outlines the ...

... report titled “Global Multiple Sclerosis Market: Trends & Opportunities (2013-18)“ provide an insight into the market dynamics and various trends and opportunities associated with the global multiple sclerosis market. The report ... contributor to the global multiple sclerosis market has been assessed. The report concludes with a brief discussion of major factors driving the global multiple sclerosis market and profiles major ...

... Report The report titled “Global Age-Related Macular Degeneration (AMD) Market: Trends & Opportunities (2013-2018)” provides an in-depth analysis of the global age-related macular degeneration market with detailed analysis of various ... Age-related macular degeneration (AMD) is a condition affecting older people, and involves the loss of the person's central field of vision. Several forms of AMD exist such as early AMD ...

... Xeljanz to gain approval in Europe (see ViewPoints: Key opinion leader casts doubt as to whether Pfizer's Xeljanz ... Xeljanz's ability to inhibit progression of structural disease. FirstWord polled US-based rheumatologists in May to ascertain how physicians were utilising Xeljanz and this week's Physician Views ...

... survival solutions with significant importance. Also, the side effects of this therapy would be tolerable by the patients, which could thus become the ... selective without the need for any genetic manipulation. “Global Oncolytic Virus Therapy Pipeline Analysis” by PNS Pharma gives comprehensive insight on the ...

... report titled “Global Testosterone Therapy Market”: Trends & Opportunities (2013-2018)” provides an in-depth analysis of the global Testosterone Therapy market with detailed analysis of symptoms, diagnosis and treatment of testosterone deficiency. The report majorly focuses on the US testosterone therapy market and also assesses ...

... or ribavirin, thus significantly reducing side-effect burden. A Physician Views poll run by FirstWord in December 2012 (among 74 US-based gastroenterologists ... one-tablet combination of sofosbuvir and ledipasvir). But what of its commercial opportunity in the meantime, assuming the drug is launched in ...

... to make it more accessible to patients. According to the “US Proton Therapy Outlook 2017” by RNCOS, the United States will be home to almost 27 such centers ... will breach the Billion dollar mark to attain revenue of US$ 1.17 Billion by 2017. The following 65 pages report provides an insight into the cancer ...

The Competitive Intelligence report Smallpox Vaccines & Therapeutics as of August 2013 provides a competitor analysis in the development pipelines of novel vaccines and therapeutics for prophylaxis of Variola virus infection and treatment of smallpox. Purchase of the pdf report includes a 6-month online ...

... to boost the growth. According to RNCOS’ new research report, “Global Gene Therapy Market Analysis”, major focus has been made on the ongoing ... therapy include cardiac conditions, genetic disorders and neurological diseases. An effective analysis of the key therapeutic areas has been included in the report. ...

... undisclosed settlement dates, based on available facts. In other words, Para IV Plus is not merely a database but is a tool with in-depth insights for every ... gives list of potential API buyers To a pharma company desirous of banking on the Para IV litigations, this tool will help them strategize their entry ...

Pricing: Japan Database: $15,000/- subscription p/a Formulating a competitive landscape of various therapeutic classes in Japan is challenging viz a viz the US and EU markets ... reliable Source in public domain 5. Large contribution of ‘Japan Only’ products - difficult to make competitive landscapes for overseas ...

Endocyte’s (ECYT) SMDC technology platform and drug pipeline caught investor’s ... our initiation report released on 19th April, 2013 on ECYT titled “Small and Powerful Targeted Therapy!

... titled ‘Global Irritable Bowel Syndrome Market: Trends and Opportunities (2012-17)’ provides an in depth analysis of IBS market on a global level. The report presents the global market sizing of IBS and ... Sucampo Executive Summary Irritable Bowel Syndrome or IBS is a gastrointestinal disorder in which the colon muscle contracts more readily. The high prevalence of this syndrome could be estimated ...

... one of the highest impact rendering drivers of the multiple sclerosis therapeutics market. Many organizations over the globe are actively involved in ... high prescription rates & price North America dominated the overall multiple sclerosis therapeutics market with revenue estimates at over 13.0 billion in 2015. ...

... be prevented. “UAE IVF Treatment Market Analysis” research report gives detailed information on following aspects related to booming IVF treatment market in UAE: Current Market Scenario IVF Treatment Market Potential Treatment cycle & Birth Rate Fertility Treatment Loan ...

... FirstWord research is provided in two comprehensive modules: The KOL Insight: HIV module provides a complete review underpinned by exclusive in-depth interviews with ... Protease inhibitors CCR5 inhibitor Expert Opinion for Real World Insights The data and analysis in the report is enriched through the ...

... GLP-1 secretion in glucose depended manner is the key trait of this class. Through this, GPR agonist controls hyperglycemia without hypoglycemia, and ...

Hemophilia is an inherited (X-linked recessive trait), lifelong bleeding disorder that prevents blood from clotting due to insufficient or lack of adequate amount of clotting factors – Factor VIII (FVIII) and Factor IX (proteins in blood that control bleeding). Plasma-derived FVIII and FIX proteins were used ...

... Intelligence Report Enzyme Replacement & Enhancement Therapies (ERT) as of January 2013 provides a competitor analysis in the development pipeline of novel enzyme replacement therapies and of enzyme enhancement therapies to treat human genetic diseases/lysosomal storage diseases and exocrine pancreatic ...

Charting the Future Multiple Sclerosis Market LandscapeOver the next five years, the global multiple sclerosis (MS) market is set to grow from $12.3 billion in 2011 to $17.3 billion in 2016. Primary d...

... of QVA-149 from fifth and final successful pivotal clinical study result (SPARK) from IGNITE program on August 30th, 2012. The fixed dose LABA ... in the US and 2012-2013 in the EU and hence any market share loss would be immaterial from Pfizer perspective. The LABA/LAMA FDC will also ...

Analyse the latest global RA market players and products, and start mapping your future market parameters with Therapy Trends’ Consensus Outlook: Rheumatoid Arthritis, which includes the following com...

What the future holds Over the next few years, the global Rheumatoid Arthritis (RA) market is expected to grow from $16.5 billion in 2011 to $23.4 billion in 2016. This expansion of the market will b...

Therapy Trends KOL Insight: Rheumatoid Arthritis analyses the current and predicted key issues, clinical advances and late-stage pipeline products in the international and US RA markets. KOL Insight g...

Gilead’s supremacy in the HIV space in 2012-18 should remain intact with the successful launch of ... , please read our report released on 3rd May, 2012 on Gilead titled “After HIV -Poised to Deliver the Best Anti-Viral Treatment Options for HCV!”

... , pelvic inflammatory diseases, etc. Today, arrays of treatment options to treat infertility are readily available in India. These include medications for ovulation induction ... IUI, IVF, and ICSI (intra cytoplasmic sperm injection). India has become one of the favored destinations for infertility treatments such as IVF due to several ...

This report analyzes the worldwide markets for Osteoporosis Therapeutics in US$ Million by the following Therapeutic Classes: Bisphosphonates, ERT Drugs, SERMs, Calcitonins, ... 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 49 companies including many key and niche ...

This report analyzes the worldwide markets for Herpes Simplex Virus Treatment in US$ Million. The report provides separate comprehensive analytics for the US, ... , Inc., Novartis International AG, Sanofi, Starpharma Holdings Limited, and Vical. Market data and analytics are derived from primary and secondary ...

Protein-based therapies have found a prominent place in the biopharmaceutical industry since the launch of human insulin product. They have become one of the most effective clinical methods to treat w...

An incisive report and dynamic analyst briefing service delivering insight from the most influential Multiple Sclerosis (MS) Key Opinion Leaders to map the current treatment landscape and analyse futu...

In this updated issue of ‘Japan-Domestic Pharma Market Summary’ for 2012, we present major 10 Thx Class in Japan which covers ~40% of total Japan domestic pharma market (~¥8.0 trillion). This will ... breakthroughs in each class – which includes products from all pharma companies operating in Japan including MNCs.

... with G551D mutation), we see little risk to Vertex (VRTX) profitability for at least next three years ... of IL28B CC Genotype. Vertex has also accelerated the pace of developing IFN-free drugs to remain in the ... 14th Feb., 2012 on Vertex titled “IFN-free Oral HCV Treatment – Vertex Not Out of the Race Yet ...

Gilead (GILD) is poised for further growth, based on the FY12 ... GILD a step closer towards its goal to deliver the “best-in-class IFN-free oral pill” for HCV. Other acquisitions ... read our report released on 10th Feb., 2012 on Gilead Sciences titled “Providing the Best Antiviral Treatment Options for HIV and HCV!”

This report analyzes the Global market for Gene Therapy in US$ Million. Annual estimates and forecasts are provided for the period 2009 through ... GenVec, Oxford BioMedica, Shenzhen SiBiono GeneTech Co., Ltd., Transgene, and Vical Inc. Market data and analytics are derived from primary and secondary research. ...

... anecdotes, market briefs, and concise summaries of research findings. The report offers an aerial view of the global oxygen therapy industry, identifies major short to medium term market challenges, and growth drivers. Regional markets elaborated upon include United States ...

HIV endemic has had devastating economic, social, health and psychological impacts over the years affecting millions of households in a significant manner over the last decade. Despite the concrete ef...

The present Competitive Intelligence report about HIV Small Molecule Therapeutics used to treat human immunodeficiency virus (HIV) infections provides a competitor evaluation in the field of marketed...

This report analyzes the worldwide markets for Autoimmune Disease Therapeutics in US$ Million by the following Therapeutic Class: Rheumatoid Arthritis (Biologics), Multiple ... 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 112 companies including many key and niche ...

This report analyzes the worldwide markets for Multiple Myeloma Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, ... , Inc., Millennium Pharmaceuticals, Seattle Genetics, and Ziopharm Oncology, Inc. Market data and analytics are derived from primary and secondary ...

This report analyzes the worldwide markets for Overactive Bladder (OAB) Therapeutics in US$ Million. The report provides separate comprehensive analytics for ... ., SALVAT Biotech, Sepracor Pharmaceuticals, Inc., and Watson Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary ...

This report analyzes the worldwide markets for Irritable Bowel Syndrome (IBS) Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year ...

Single User PDF Format: US$ 1,800.00 Multi-User License: US$ 2,800.00 Hard Copy: US$ 2,200.00 CD-ROM: US$ 2,200.00 Within the global pharmaceutical industry, protein therapeutics has b...

Medivir’s Xerese fetched $45m for the company from Meda AB for US, ... , please read our report released on 29th June on MVIR titled “Monetizing Cold Sores to Focus On Improved Protease Inhibitors for HCV Treatment” and ...